The extent of resection and the size of tumor are predictive of perioperative blood transfusion[13]. Cockbain et al[14] concluded that hilar cholangiocarcinoma resections are a risk factor for excessive bleeding due to the technical difficulty as these resections may include lymph node dissection, caudate resection, resection and reconstruction of hepatic inflow. On the other hand, OLT for hepatocellular carcinoma (HCC) was found to be negative predictor for massive blood transfusion in a retrospective study by Cywinski et al[15].

Assessment of severity of liver disease is most commonly done by Child Pugh Turcotte (CTP) and Model for end stage disease (MELD). Association of severity of liver disease with perioperative blood loss is controversial. Findlay et al[16], Massicotte et al[17], and Roullet et al[18] in their recent study concluded that it is not an independent predictor of bleeding and blood product requirement.

Contradictory to these findings, McCluskey et al[19] derived a risk index for the prediction of massive blood transfusion in OLT. In their derived risk index, two of the variables included in calculating the MELD score-preoperative creatinine and International Normalized Ratio (INR) were found to be independent predictors of bleeding, although the MELD score itself was less predictive. In consistence, Mangus et al[20] found high MELD scores to a one of the risk factors found to be significantly associated with increased bleeding and transfusion requirements. Frasco et al[3] also showed a positive association between MELD score and transfusion requirement during OLT. In 2006, a high MELD scores (> 30) was found to be significantly associated with increased bleeding and transfusion requirements compared to patients with low MELD scores (< 30)[21]. Higher MELD score was found to be highly statistically significant predictor of massive blood transfusion in a recent retrospective study by Cywinski et al[15]. Thus, if a MELD score is greater than 30 or patient is Child grade B or C, it is prudent to assume the probability of increased blood loss perioperatively even though studies show conflicting results.

Impaired hemostasis in patients with advanced liver disease is multifactorial. Predominant factors includes impaired coagulation factor synthesis, synthesis of dysfunctional coagulation factors, accelerated consumption of coagulation factors and platelets, splenomegaly causing platelet sequestration and consumption, altered clearance of activated coagulation factors including factors of the fibrinolytic pathway contributing to hyperfibrinolysis, Accelerated intravascular coagulation and fibrinolysis (AICF) and qualitative disorders of platelet function are all contributory[22,23].

Recent advances in the understanding of the coagulopathy in patients with liver disease have led to the concept of the rebalanced theory of hemostasis in these patients as alterations in both anti and procoagulant pathways balance each other in patients with liver disease[24].

It has been shown that correction of coagulation defects before the anhepatic phase is not necessary[25]. There is a relatively poor correlation between bleeding and laboratory indices of coagulation (PT/INR) in patients with chronic liver disease[22,23]. Pre transplant higher INR and lower platelet counts were found to be highly statistically significant predictors of higher intraoperative blood product usage in retrospective study by Cywinski et al[15].

Cywinski et al[15] in their retrospective study reported that higher intraoperative blood product usage was more frequent in patients undergoing OLT with history of previous upper abdominal surgery. This result has been concordant with the results of previous studies by Steib et al[4], Palomo Sanchez et al[9] in which previous abdominal surgery was independently associated with massive transfusion intra operatively[9]. However, this association was not derived in studies by other investigators[18,26].

Findlay et al[16] did not find any significant association between retransplantation and blood usage. These results were similar to previously published results of Motschman et al[27].

Transfusion requirements depend not only on the intraoperative blood loss but also on the threshold for when transfusions of different products are initiated. Therefore, comparison of intraoperative transfusion requirements from different studies may be inherently biased by inability to account for differences in transfusion triggers and clinical practices. Low starting hemoglobin (Hb) value represents the most important indicator for the need for transfusion as shown by Massicotte et al[6]. Despite pre operative hemoglobin being an important predictor of intra operative RBC transfusion in various studies; the cut off threshold for the same has not been clearly reported in them[20]. In a study by Steib et al[4], one of the three preoperative risk factor predictive of high blood loss was preoperative low Hb. The investigators concluded that patients with an initial low Hb below 10 gm/dL would require transfusion in order to reach the selected trigger point in their study.

The conventional method for liver transplantation requires clamping of both portal flow from the viscera and caval flow from the lower body.

Piggyback hepatectomy (PGB) is a surgical technique increasingly utilized in both DDLT and LDLT. The pseudonym Caval preservation technique is justified because it avoids clamping of the vena cava while maintaining flow from the lower body back to the heart throughout the transplant. Preservation of cardiac preload maintains hemodynamic stability and avoids large infusions of fluid volume, vasopressors, and need for venovenous bypass (VVB). The total duration of warm ischemia time is significantly reduced, as one less anastomosis is required prior to reperfusion.

The conventional method would seem to be associated with lesser blood loss and transfusion requirements because PGB is technically more demanding and time consuming than the conventional approach. However, studies suggest otherwise.

Maguns et al[20] concluded that blood loss and blood product usage with PGB technique are similar to or better than those for the conventional technique. It is the preferred method in high-risk patients such as the elderly or those with poor physiologic reserve and may be associated with less perioperative morbidity and mortality.

Previously published studies also concluded that PGB is a potentially superior technique given its benefits of avoiding VVB, maintaining hemodynamic and physiologic stability, decreasing warm ischemia time and association with significantly lower blood loss and transfusion requirements[28]. As summarized by an analysis by the Cochrane database[29], no trial has till date shown superiority of one technique over the other.

Blood losses during liver resection are usually greatest at the stage of parenchymal transaction. Selective clamping of the vasculature prevents excessive blood loss during this phase. Commonly used methods for clamping are: (1) Complete inflow occlusion (Pringle maneuver) - Method most commonly used. Blood loss associated with this method is lesser than the intermittent method. Greater degree of ischemic injury to the liver parenchyma is however reported with this method; and (2) Intermittent clamping or (ischemic preconditioning technique)-This technique has shown to reduce ischemic injury during liver resection, more so in cirrhotic livers. On a comparative analysis however, intermittent clamping has been shown to be associated with more bleeding than the continuous clamping method[30].

Amongst the newer devices available for liver parenchymal transaction, the Cavitron Ultrasonic Surgical Aspirator (CUSA) is universally used[31]. Lesurtel et al[32] compared four different techniques of liver transaction in a prospective randomized clinical trial. Techniques compared were - conventional clamp crushing technique, CUSA, Hydro-jet, and a dissecting sealer in 100 non-cirrhotic patients undergoing major liver resections. Significantly reduced resection time, costs along with a significant reduction in intra operative blood loss was seen with the clamp-crashing technique.

Deakin et al[26] also concluded that that technical improvement in surgery has led to a threefold reduction in the blood transfusion rate. The changes enumerated were-increased use of diathermy dissection with meticulous suture ligation of vessels difficult to control by diathermy, increase use of VVB and the use of sophisticated coagulation devices like Argon Beam Coagulator. This study was done in the pre PGB technique era and these surgical techniques have more or less become the norm in OLT.

The experience of the surgical team was found to be an independent predictor of transfusion[33]. Steib et al[4] concluded that there is a significant decrease in the number of patients undergoing high blood loss with the progressive experience of the surgical team, but it was not found to be an independent predictor of blood loss and transfusion requirements.

Performance of liver resection under low central venous pressure (CVP) has been extensively studied[34]. Low CVP (defined as a pressure < 5 mmHg) can be attained by volume contraction, vasodilators, forced diuresis, adequate neuromuscular blockade, reduction of respiratory tidal volume and applied PEEP.

Conservative transfusion policy and volume contraction reduces perioperative transfusion requirement by avoidance of fluid overload. Prophylactic correction of deranged routine tests of coagulation results in administration of large volumes of plasma and/or platelet concentrates. Pathophysiological changes in patients with ESLD including portal hypertension and numerous collaterals, increased plasma volume with redistribution of plasma volume to splanchnic bed, and disturbed cardiac function with peripheral vasodilatation, causes rapidly administered fluids and blood products to further increase the portal and central venous pressure. This results in bleeding with surgical trauma probably due to venous congestion[35].

Jones et al[36] were the first to show that intra operative blood loss during liver resection correlated almost linearly with the CVP. The safety and benefits of restricted intra operative fluids and low CVP in patients undergoing liver transplant was studied by Schroeder and colleagues. They compared outcome variables of patients with two different fluid policies in two different centers. The target in the intervention group of a low CVP (< 5 mmHg) was achieved by fluid restriction, whereas a normal CVP of (7-10 mmHg) was maintained in the other group in the second center. Decreased transfusion requirements of RBC, FFP and platelets was observed in the low CVP group as compared with the normal CVP group[37].

The maintenance of a low CVP intra operatively in cirrhotic patients undergoing liver resection was not associated with any significant increase in mortality and morbidity. Significantly reduced intraoperative transfusion of blood and blood products along with decreased hospital stay was observed in the low CVP group. There was no derangement in postoperative hepatic and renal function in the study group[38].

Hashimoto et al[39] studied the effect of prophylactic phlebotomy and withdrawal of calculated amount of blood (0.7% of the patient’s body weight) vs no withdrawal of blood in a randomized prospective study of healthy donors scheduled for partial liver resection for LDLT. At the beginning of parenchymal transection CVP was significantly lower in the phlebotomy group [median 5 (range 2-9) cm H₂O vs 6 (range 2-13) cm H₂O) as compared with controls. Post operative outcomes were comparable between the groups[39].

In another study in liver transplant recipients, Massicotte et al[35] achieved a low CVP by volume contraction and intraoperative phlebotomy. Expansion of blood volume post phlebotomy (at the beginning of the case) was not done. They concluded that avoidance of plasma transfusion; starting Hb value and maintenance of a low CVP prior to the anhepatic phase were associated with a significant decrease in blood and blood products during this study[35].

On the other hand maintenance of a low CVP during liver resections is associated with a increased risk of complications including air embolism, systemic tissue hypoperfusion and renal failure[7,35,37]. In their study Schroeder and colleagues observed an increase in 30 d mortality and dialysis requirements with higher post operative peak creatinine levels in patients with low intra operative CVP[37].

Hyperfibrinolysis plays a significant role in nonsurgical blood loss in patients undergoing OLT requiring massive transfusion of blood products. Hyperfibrinolysis always occurs late in the anhepatic phase and immediately after the reperfusion of the graft. An increased level of t-PA because of an increased release from the damaged ischaemic endothelium of the graft and lack of its hepatic clearance in the anhepatic phase is the principal causative factor. Also there is associated consumption of alpha-2 antiplasmin and plasminogen activator inhibitor type-1 (PAI-1)[5,40]. The beneficial effects of antifibrinolytics to reduce the bleeding and transfusion requirements in patients undergoing cardiac surgery initiated the assessment of antifibrinolytics in liver transplant.

Dalamu et al[41] documented a significant reduction in PRBC transfusion in a prospective double blind randomized study conducted to compare the efficacy of prophylactic infusion of tranexamic acid (TA) or epsilon aminocaproic acid (EACA) with placebo in reducing blood loss and transfusion requirement during LT. In this study, TA and EACA were given prophylactically at a rate of 10 and 16 mg/kg per hour respectively. Thirty-one percent of patients in the TA group did not receive any PRBC transfusion. Also the TEG profiles of the patients given TA in the reperfusion phase were better in TA group. There was no difference in transfusion requirements after OLT, or thromboembolic events, reoperations or mortality between the groups. Boylan et al[42] found that a larger dose, i.e., 40 mg/kg per hour of TA reduced not just the intraoperative blood loss but also the transfusion of plasma, platelet and cryoprecipitate. However a Cochrane Hepato-Biliary Group metaanalysis, did not show a significant reduction in blood and blood product requirements in patients receiving tranexamic acid vs controls[43].

Nehaus et al[44] first reported Aprotinin use in a study in 1989. They reported decreased blood loss, transfusion requirements and duration of surgery with the use of aprotinin in the dose of 2 million KIU (Kallikrien inhibitory units). Studies by Porte et al[45], Findlay et al[46] have also shown that there is a decrease in transfusion requirement with use of aprotinin. In a review of the use of aprotinin in OLT, Lentschener and colleagues concluded that prophylactic use of large dose aprotinin decreases blood loss and transfusion requirements only when OLT is associated with significant blood loss and does not alter postoperative outcomes[47]. The efficacy of TA vs Aprotinin in reducing blood loss and transfusion requirements during OLTx was studied by Massicotte et al[48]. Administration of TA and Aprotinin was found to be comparable in terms of intraoperative blood loss and transfusion requirements. Molenaar et al[49] in their study concluded that although both Aprotinin and TA significantly reduced RBC transfusion requirements; significant reduction in intraoperative FFP transfusions was achieved with Aprotinin only. Post operative thromboembolic events and mortality was not increased in patients receiving antifibrinolytics.

However, other studies failed to show a significant difference in the transfusion of red blood cells, fresh frozen plasma (FFP), cryoprecipitate, and platelets between the aprotinin-treated group and the placebo group[50].

Recombinant factor VIIa (rFVIIa) till date is approved by the United States Food and Drug Administration (FDA) for hemophilia only, but a large number of case reports and studies have reported the use of rFVIIa in uncontrolled hemorrhage due to trauma or surgery including OLT.

Hendriks et al[51] first reported that prophylactic administration of 80 μg/kg of rFVIIa in adult cirrhotic patients undergoing OLT led to significant reductions in median total PRBC requirements, although one of the treated patients developed hepatic artery thrombosis. Lodge et al[52] were not able to demonstrate any reduction in RBC requirement in rFVIIa-treated patients compared to placebo. The efficacy of rFVIIa in reducing intraoperative blood loss is only modest at the cost of an increased incidence of thromboembolic episodes specially in patients with intracerebral hemorrhage and those undergoing cardiac surgery[53]. Thus, rFVIIa cannot be recommended as a universal prophylaxis to reduce transfusion requirements during OLT particularly considering the high cost of rFVIIa.

New point of care tests are now available which allow monitoring of the haemostasis in the operation theatre which is essential in patients with pre-existing haemostatic abnormalities or in profusely bleeding patients with complex and rapidly changing coagulation profile. Devices assessing viscoelastic properties of whole blood are available include thromboelastography (TEG), rotation thromboelastometry and Sonoclot analysis.

TEG can assist in treatment of intraoperative bleeding by identifying the cause. In combination with clinical assessment of bleeding, it also facilitates selective replenishment of deficient blood components and use of specific drug treatments (antifibrinolytics). Various studies have demonstrated a significant reduction in intraoperative blood and component therapy with coagulation monitoring through TEG when compared with traditional “clinician-directed” transfusion management. Wang et al[54] reported that the FFP requirement during OLT in patients being monitored with TEG was lower than patients corrected for deranged PT/INR values using accepted transfusion thresholds.

Still no consensus exists on transfusion practices in liver surgeries especially OLT. There is high variability in the use of blood products in liver resection surgeries with most of the use not being evidence based. Most centers follow the ASA practice guidelines for the transfusion of blood products during OLT. The threshold for RBC, plasma and platelet transfusion is a Hb of 60 to 100 g/L; INR value > 1.5 and platelet < 50000/mL, respectively. Despite following these guidelines a wide range of transfusion rates exist between centers and even among anesthesiologists in the same center.

Massicotte et al[8] in their prospective study on 206 patients used aprotinin, a low CVP and a transfusion trigger of 60 gm for administering PRBC transfusion. They did not use PGB, VVB or prophylactic correction of coagulopathy. The investigators concluded that coagulation defects were not linked to PRBC transfusion and there is no benefit of prophylactic correction of coagulation disorders in the absence of uncontrollable bleeding. The use of FFP was the strongest predictor for PRBC transfusion and associated with decrease in one-year survival rate[8].

Autologous blood transfusion and intra operative blood salvage has shown to reduce allogeneic blood transfusion in patients undergoing surgery with high risk of intraoperative blood loss and transfusion. These techniques play an important role in management of special patient populations (Jehovah’s Witnesses and patients with rare blood groups) undergoing major surgeries including transplantation.

In adult patients undergoing elective surgery cell salvage was concluded to be an efficacious technique in reducing the need for allogeneic blood transfusion by a Cochrane Collaboration meta-analysis[55]. The cost effectiveness of this technique as compared to allogenic blood transfusion was also corroborated by Waters et al[56] in their review. It has also been reported to improve conservation of erythrocytes and reduce exposure of patients to blood and blood components[57,58].

Despite above-mentioned evidence the role of cell salvage techniques in OLT remains controversial with studies reporting higher blood loss with its use due to fibrinolysis and increased costs. A increase in transfusion requirements in liver transplant recipients was reported by Hendriks et al[33] with the use of cell salvaged blood with salvaged blood hypothesized as a cause of excessive blood loss. Increased requirements of RBCs, FFP, cryoprecipitate, and platelets in patients given cell salvaged blood have been shown by other studies[59,60]. Degradation products of Fibrinolysis in the salvaged blood either from blood cells or from the transplanted liver, that are not cleared by washing of RBC’s in the cell saver are postulated to be the cause of increased blood loss in these patients[59].

However with the decrease in intra operative blood loss in patients undergoing OLT; the cost effectiveness of the technique (requiring intraoperative salvage and use of two or more blood units) in comparison to allogenic blood transfusion is questionable. Thus, the use of cell salvage is helpful in OLT case with anticipated high blood loss.